Market analysis of COPD and sleep apnea treatment in Europe: Assessing trends, innovations, and growth opportunities.

The project provided strategic insights to optimize positioning, address unmet needs, and drive growth in the European COPD and sleep apnea market.

Outcome

  • Analysis of the COPD and sleep apnea market in Europe, covering market size, value, regional segmentation, and usage trends for medical gases and related products.
  • Overview of key players, their market shares, and customer purchasing behaviors, highlighting decision-making criteria and supplier preferences.
  • Identification of unmet needs, pain points, and opportunities for innovation in gas-based therapies, supported by regulatory insights to ensure compliance and facilitate market expansion.

KEY INTELLIGENCE OBJECTIVES

  • Size the COPD and sleep apnea treatment market, segmented by region, type of establishment, and treatment modality.
  • Examine the market structure, focusing on key players, their market shares, and distribution channels for medical oxygen: liquid, compressed, valves, POC, CPAP, etc.
  • Identify market growth drivers and barriers, including regulatory dynamics, patient demographics, and technological advancements in treatment delivery.
  • Analyze customer (patient) purchasing behaviors, covering decision-making processes, criteria for selecting suppliers and products, and factors influencing product preferences.
  • Map the competitive landscape, assessing the strengths, weaknesses, and market perceptions of major gas manufacturers and home-use solution providers in COPD and sleep apnea.
  • Assess the role of healthcare professionals (HCPs) in treatment pathways, evaluating their knowledge, experience, and openness to new gas-related solutions for COPD and sleep apnea.
  • Evaluate unmet needs and pain points of patients, HCPs, and healthcare institutions in managing COPD and sleep apnea, identifying opportunities for innovation in gas-based therapies.
  • Analyze the regulatory and certification requirements for gas usage in COPD and sleep apnea treatment, ensuring compliance across the European market.
  • Define the profile of the ideal supplier for gas solutions in COPD and sleep apnea care, with insights into aligning product offerings and services with market expectations.

Geography

  • Western Europe
  • Central & Eastern Europe
  • Middle East
  • Africa
  • North America
  • South America
  • Other

    • Go back to our case studies

    Welcome to EMBS Group

    Please review the basic information regarding the processing of personal data. The Data Administrator is EMBS GROUP Sp. z o.o. Sp. k. You can contact us via email at gdpr@embs-group.com or our registered office (Poland, 30-224 Kraków, Aleja Sosnowa 2a).

    Please note that any personal data you provide may be used only for the specific purpose for which it was shared. Although providing your data is voluntary, not doing so may limit certain services or actions.

    For more detailed information on processing personal data, including exercising your rights, please refer to our Privacy Policy.

    Accept

    Get the report

    SUBSCRIBE TO MARKET MINDS

    Smart decisions start here.
    Unlock hard-to-get market intelligence to empower your next strategic move.

    Contact us

    Want to talk about your business challenge with us?
    Let us know, we’re always happy to talk.

    EMBS GROUP Sp. z o.o. Sp. k., as the Data Administrator, will process the personal data provided above to respond to the message sent via the form. You can contact us at gdpr@embs-group.com or our registered office (Poland, 30-224 Kraków, Aleja Sosnowa 2a). The full text of the information clause is available in the Privacy Policy.
    Privacy Overview

    EMBS Group, as the Data Administrator, uses cookies to enhance user experience and analyze website traffic. You can change your cookie settings at any time. For more information, please see our Privacy Policy.